Anatomic Stage III Breast Cancer AJCC v8 Not Yet Recruiting Phase 2 Trials for Olaparib (DB09074)

IndicationStatusPhase
DBCOND0109625 (Anatomic Stage III Breast Cancer AJCC v8)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04090567Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerTreatment